Phibro Animal Health Corp. (PAHC)

38.49 +0.51 (+1.34%) USD  |  NASDAQ  |  Oct 16, 11:21
More

Phibro Animal Health SG&A Expense (TTM) : 318.12M for June 30, 2026

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2012. Start Trial.
Date Value
June 30, 2026 318.12M
March 31, 2026 308.17M
December 31, 2025 298.20M
September 30, 2025 292.20M
June 30, 2025 289.48M
March 31, 2025 281.92M
December 31, 2024 270.54M
September 30, 2024 257.12M
June 30, 2024 259.78M
March 31, 2024 243.94M
December 31, 2023 241.25M
September 30, 2023 239.88M
June 30, 2023 226.39M
March 31, 2023 229.03M
December 31, 2022 224.47M
September 30, 2022 211.31M
June 30, 2022 206.41M
March 31, 2022 201.55M
December 31, 2021 198.15M
September 30, 2021 198.14M
June 30, 2021 196.51M
March 31, 2021 188.24M
December 31, 2020 187.44M
September 30, 2020 188.56M
June 30, 2020 187.64M
Date Value
March 31, 2020 198.44M
December 31, 2019 192.52M
September 30, 2019 185.96M
June 30, 2019 181.39M
March 31, 2019 169.59M
December 31, 2018 169.87M
September 30, 2018 169.91M
June 30, 2018 167.95M
March 31, 2018 166.15M
December 31, 2017 154.22M
September 30, 2017 152.11M
June 30, 2017 150.30M
March 31, 2017 150.20M
December 31, 2016 158.34M
September 30, 2016 157.26M
June 30, 2016 156.38M
March 31, 2016 156.78M
December 31, 2015 155.29M
September 30, 2015 151.80M
June 30, 2015 148.72M
March 31, 2015 150.03M
December 31, 2014 148.25M
September 30, 2014 146.09M
June 30, 2014 143.98M
March 31, 2014 129.39M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Globus Medical, Inc. 1.217B
Zoetis, Inc. 2.378B
ANI Pharmaceuticals, Inc. 324.76M
Corcept Therapeutics, Inc. 556.47M
Veru, Inc. 16.05M